Global NGS Sample Preparation Market Size (2024 - 2029)

The NGS sample preparation market is anticipated to experience significant growth, driven by the increasing prevalence of infectious diseases and advancements in sequencing technologies. The market's expansion is further supported by the critical role NGS sample preparation played during the COVID-19 pandemic, which highlighted its importance in developing rapid sequencing technologies for viral genomic analysis. Despite the challenges posed by high equipment costs and stringent regulations, the market is expected to continue its upward trajectory due to the introduction of new, cost-effective NGS technologies that offer superior efficiency compared to traditional methods.

Market Size of Global NGS Sample Preparation Industry

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:
NGS Sample Preparation Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
CAGR 12.40 %
Fastest Growing Market Asia-Pacific
Largest Market North America
Market Concentration Medium

Major Players

NGS Sample Preparation Market Major Players

*Disclaimer: Major Players sorted in no particular order

setting-icon

Need a report that reflects how COVID-19 has impacted this market and its growth?

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

NGS Sample Preparation Market Analysis

The NGS sample preparation market is expected to register a CAGR of 12.4% over the forecast period.

The outbreak of the COVID-19 pandemic has impacted the NGS sample preparation market. The increasing coronavirus cases worldwide led to the need to develop effective and quick sequencing technologies to rebuild the genomic sequence of SARS-CoV-2, which was the etiological agent of COVID-19. It was critical in the development of diagnostic molecular tests as well as the development of efficient tactics and strategies to slow the spread of the pandemic. For instance, in August 2020, Helix Laboratory received the U.S. FDA emergency use authorization for NGS based COVID-19 test, which is designed to detect the SARS-CoV-2 spike protein gene in upper respiratory specimens. This next-generation sequencing was applied
for the study of COVID-19 and has greatly promoted SARS-CoV-2 original tracking. Since next-generation sequencing (NGS) sample preparation played a vital role during the pandemic, thus the market witnessed positive growth and is expected to continue the upward trend over the forecast period.

The rising infectious disease prevalence reduced sequencing cost, and technical advancement in NGS platforms are the major factors propelling the market growth. With the increasing prevalence of infectious diseases, NGS sequencing technologies have swiftly become the method of choice in virology for a wide range of applications, including the detection of novel viruses from metagenomic samples, reconstruction of whole or almost complete viral genome sequences, and viral evolution and subspecies analysis. For instance, as per the WHO August 2022 Influenza Update, National Influenza Centers (NICs) and other national influenza laboratories from 120 countries, regions, or territories submitted data to FluNet from 11 July 2022 to 24 July 2022. Over 145,086 samples were analyzed by the WHO Global Influenza Surveillance and Response System (GISRS) laboratories during that time. Among the 6,449 people who tested positive for influenza viruses, 97.7% had influenza A, and 2.3% had influenza B.

Similarly, according to the WHO report 2021, each year, typhoid fever is estimated to affect 21 million people worldwide. Similarly, according to the CDC, 30,000 cases of yellow fever occur annually, out of which 90.0% occur in Africa. Therefore, increasing cases of infectious diseases across the globe is anticipated to propel market growth over the forecast period.

The key and small players' launch of new NGS technologies drive market growth. NGS technologies have replaced traditional sequencing methods because of the low cost and high sequencing efficiency. For instance, according to Illumina, in 2021, the cost of next-generation sequencing (NGS) has decreased dramatically since the completion of the Human Genome Project. Illumina has helped reduce the cost of NGS, enabling the USD 1000 human genome. Therefore, new product launches are expected to surge the market growth over the forecast period.

However, the high costs of NGS sample preparation equipment and strict regulation associated with NGS Sample preparation are likely to impede the market growth.

NGS Sample Preparation Industry Segmentation

As per the scope of this report, next-generation sequencing (NGS) is a high-throughput technology that can acquire insight into any species at the genomic, transcriptomic, or epigenetic level. NGS has made it possible to gain genetic information from samples much faster with more reliability and low cost than ever before. Rapid developments in sequencing technologies have resulted in a significant increase in throughput capabilities and a cost reduction. The NGS Sample Preparation Market is Segmented by Product Class (Reagent and Consumables, Workstations), Application (Diagnostics, Drug Discovery, and Other Applications), End User (Hospitals and Clinics, Pharmaceutical and Biotechnology Companies, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 countries across major global regions. The report offers the value (in USD million) for the above segments.

By Product Class
Reagent and Consumables
Workstations
By Applications
Diagnostics
Drug Discovery
Other Applications
End User
Hospitals and Clinics
Pharmaceutical and Biotechnology Companies
Other End Users
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle East and Africa
South America
Brazil
Argentina
Rest of South America
Need A Different Region Or Segment?
Customize Now

Global NGS Sample Preparation Market Size Summary

The NGS sample preparation market is poised for significant growth, driven by advancements in sequencing technologies and the increasing prevalence of infectious diseases. The COVID-19 pandemic underscored the importance of next-generation sequencing in rapidly developing diagnostic tests and tracking viral mutations, thereby boosting market demand. The shift from traditional sequencing methods to NGS due to its cost-effectiveness and efficiency has further propelled market expansion. Key players are continuously launching new technologies and forming strategic partnerships, which are expected to sustain the market's upward trajectory. Despite challenges such as high equipment costs and stringent regulations, the market is anticipated to grow robustly over the forecast period.

North America is expected to be a major contributor to the market's growth, fueled by technological advancements, product launches, and increased adoption of NGS technologies. The region's focus on addressing health disparities and the burden of infectious and chronic diseases supports this trend. The competitive landscape is characterized by a few dominant players, including Illumina, Agilent Technologies, and Thermo Fisher Scientific, who are actively expanding their portfolios and capabilities. These developments, along with substantial funding and collaborations, are likely to create new opportunities and drive the NGS sample preparation market forward.

Explore More

Global NGS Sample Preparation Market Size - Table of Contents

  1. 1. MARKET DYNAMICS

    1. 1.1 Market Overview

    2. 1.2 Market Drivers

      1. 1.2.1 Rising Prevalence of Infectious Diseases

      2. 1.2.2 Reduced Cost of Sequencing

      3. 1.2.3 Technical Advancement in NGS Platforms

    3. 1.3 Market Restraints

      1. 1.3.1 High Costs of NGS Sample Preparation Equipment

      2. 1.3.2 Strict Regulation Associated with NGS Sample Preparation

    4. 1.4 Porter's Five Force Analysis

      1. 1.4.1 Threat of New Entrants

      2. 1.4.2 Bargaining Power of Buyers/Consumers

      3. 1.4.3 Bargaining Power of Suppliers

      4. 1.4.4 Threat of Substitute Products

      5. 1.4.5 Intensity of Competitive Rivalry

  2. 2. MARKET SEGMENTATION (Market Size by Value - USD Million)

    1. 2.1 By Product Class

      1. 2.1.1 Reagent and Consumables

      2. 2.1.2 Workstations

    2. 2.2 By Applications

      1. 2.2.1 Diagnostics

      2. 2.2.2 Drug Discovery

      3. 2.2.3 Other Applications

    3. 2.3 End User

      1. 2.3.1 Hospitals and Clinics

      2. 2.3.2 Pharmaceutical and Biotechnology Companies

      3. 2.3.3 Other End Users

    4. 2.4 Geography

      1. 2.4.1 North America

        1. 2.4.1.1 United States

        2. 2.4.1.2 Canada

        3. 2.4.1.3 Mexico

      2. 2.4.2 Europe

        1. 2.4.2.1 Germany

        2. 2.4.2.2 United Kingdom

        3. 2.4.2.3 France

        4. 2.4.2.4 Italy

        5. 2.4.2.5 Spain

        6. 2.4.2.6 Rest of Europe

      3. 2.4.3 Asia-Pacific

        1. 2.4.3.1 China

        2. 2.4.3.2 Japan

        3. 2.4.3.3 India

        4. 2.4.3.4 Australia

        5. 2.4.3.5 South Korea

        6. 2.4.3.6 Rest of Asia-Pacific

      4. 2.4.4 Middle East and Africa

        1. 2.4.4.1 GCC

        2. 2.4.4.2 South Africa

        3. 2.4.4.3 Rest of Middle East and Africa

      5. 2.4.5 South America

        1. 2.4.5.1 Brazil

        2. 2.4.5.2 Argentina

        3. 2.4.5.3 Rest of South America

Global NGS Sample Preparation Market Size FAQs

The Global NGS Sample Preparation Market is projected to register a CAGR of 12.40% during the forecast period (2024-2029)

Illumina, Inc., Agilent Technologies, Inc., Thermo Fisher Scientific Inc., PerkinElmer Inc. and F. Hoffmann-La Roche Ltd are the major companies operating in the Global NGS Sample Preparation Market.

NGS Sample Preparation Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)